Skip to main content

Advertisement

Log in

Longitudinal perceptions of the side effects of chemotherapy in patients with gynecological cancer

  • Original Article
  • Published:
Supportive Care in Cancer Aims and scope Submit manuscript

Abstract

Purpose

This study aimed to assess the incidence and difference of side effects among six courses of chemotherapy (C/T) in gynecological cancer patients.

Methods

The study period was from Sep. 2010 to Dec. 2011 at the Kaohsiung Veterans General Hospital in Taiwan. The treating protocols, courses, and drugs of C/T in patient were considered according to the different malignant cancers and clinical conditions. The patient data of age, marriage status, education, religion, and experiences of C/T were collected. The patients’ or their families’ reported side effects of C/T were recorded daily from the beginning of C/T to the 10th day after C/T in each cycle and every course of C/T.

Results

Total 89 patients enrolled into the study received total 450 courses of C/T. The mean age was 54.52 ± 11.02. Ovarian cancer was the most common malignant disease (64.0%). The most often combination of drugs used was Taxol and carboplatin (40.9%). Patients complained peripheral numbness of limbs, with the highest incidence of 58.6%. The side effects with incidence about 50% were decreased fatigue (55.0%) and hair loss (49.9%). Other side effects with different levels of incidence were also noticed, such as lack of appetite, changes in taste, and muscle ache. The incidences of peripheral limb numbness and hair loss were increased with following courses of C/T. The high incidence of fatigue did not show variation between different courses of C/T.

Conclusion

This study revealed the incidence of side effects and occurrence timing during C/T in patients with gynecological cancer. These data provide substantial information to patients and their families to understand the potential side effects of C/T courses, which might increase their compliance in receiving adjuvant C/T. Relieving the side effects in C/T would be important to improve their quality of daily life and treatment willingness.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1

Similar content being viewed by others

References

  1. American Cancer Society (2015) Cancer facts and figures 2015. American Cancer Society, Atlanta

    Google Scholar 

  2. Surveillance, Epidemiology, and End Results (SEER) Program of the National Cancer Institute (NCI). SEER cancer statistics factsheets: Cervix uteri cancer. Available at: http://seer.cancer.gov/statfacts/html/cervix.html. Accessed 29 Sept 2014

  3. SEER, NCI. SEER cancer statistics factsheets: endometrial cancer. Available at: http://seer.cancer.gov/statfacts/html/corp.html. Accessed 29 Sept 2014

  4. SEER, NCI. SEER cancer statistics factsheets: ovary cancer. Available at: http://seer.cancer.gov/statfacts/html/ovary.html. Accessed 29 Sept 2014

  5. SEER, NCI. SEER cancer statistics factsheets: vulvar cancer. Available at: http://seer.cancer.gov/statfacts/html/vulva.html. Accessed 29 Sept 2014

  6. Surveillance, Epidemiology, and End Results (SEER) (2013) Program of Ministry of Health and Welfare, Taiwan, 2013. Available at: http://www.mohw.gov.tw/cht/DOS/Statistic.aspx?f_list_no=312&fod_list_no=2747

  7. Gloeckler Ries LA et al (2013) Cancer survival and incidence from the Surveillance, Epidemiology, and End Results (SEER) program. Oncologist 8(6):541–552

    Article  Google Scholar 

  8. Sun CC, Ramirez PT, Bodurka DC (2007) Quality of life for patients with epithelial ovarian cancer. Nat Clin Pract Oncol 4(1):18–29

    Article  Google Scholar 

  9. Seretny M et al (2014) Incidence, prevalence, and predictors of chemotherapy-induced peripheral neuropathy: a systematic review and meta-analysis. PAIN® 155(12):2461–2470

    Article  Google Scholar 

  10. Mock V, Atkinson A, Barsevick A, Cella D, Cimprich B, Cleeland C et al (2000) NCCN practice guidelines for cancer-related fatigue. Oncology (Williston Park) 14:151–161

    CAS  Google Scholar 

  11. Cella D, Davis K, Breitbart W, Curt G (2001) Fatigue coalition. Cancer-related fatigue: prevalence of proposed diagnostic criteria in a United States sample of cancer survivors. J Clin Oncol 19:3385–3391

    Article  CAS  Google Scholar 

  12. Ruffer JU, Flechtner H, Tralls P, Josting A, Sieber M, Lathan B et al (2003) Fatigue in long-term survivors of Hodgkin’s lymphoma; a report from the German Hodgkin Lymphoma Study Group (GHSG). Eur J Cancer 39:2179–2186

    Article  CAS  Google Scholar 

  13. Vogelzang NJ, Breitbart W, Cella D, Curt GA, Groopman JE, Horning SJ et al (1997) Patient, caregiver, and oncologist perceptions of cancer-related fatigue: results of a tripart assessment survey. The Fatigue Coalition. Semin Hematol 34(3 Suppl 2):4–12

    CAS  PubMed  Google Scholar 

  14. Lou Y, Yates P, McCarthy A, Wang H (2013) Fatigue self-management: a survey of Chinese cancer patients undergoing chemotherapy. J Clin Nurs 22(7–8):1053–1065

    Article  Google Scholar 

  15. Shields K, Craig C, Baxter L, Renda L, Pipe J, Monk B, Chase D (2015) Cancer-related fatigue in gynecologic oncology patients undergoing chemotherapy. Gynecol Oncol 137(3):596

    Article  Google Scholar 

  16. Wang SC, Borison HL (1950) The vomiting center: a critical experimental analysis. Arch Neurol Psychiatr 63:928–941

    Article  CAS  Google Scholar 

  17. Miller AD, Wilson VJ (1983) “Vomiting center” reanalyzed: an electrical stimulation study. Brain res 270:154–158

    Article  CAS  Google Scholar 

  18. Schmoll HJ, Aapro MS, Poli-Bigelli S et al (2006) Comparison of an aprepitant regimen with a multiple-day ondansetron regimen, both with dexamethasone, for antiemetic efficacy in high-dose cisplatin treatment. Ann Oncol 17:1000–1006

    Article  CAS  Google Scholar 

  19. Pater JL, Lofters WS, Zee B et al (1997) The role of the 5-HT3 antagonists ondansetron and dolasetron in the control of delayed onset nausea and vomiting in patients receiving moderately emetogenic chemotherapy. Ann Oncol 8:181–185

    Article  CAS  Google Scholar 

  20. Paul J, Hesketh N (2008) Chemotherapy-induced nausea and vomiting. Engl J Med 358:2482–2494

    Article  Google Scholar 

  21. Kris MG et al (2006) American Society of Clinical Oncology guideline for antiemetics in oncology: update 2006. J Clin Oncol 24(18):2932–2947

    Article  CAS  Google Scholar 

  22. Gralla RJ, Osoba D, Kris MG et al (1999) Recommendations for the use of antiemetics: evidence-based, clinical practice guidelines. American Society of Clinical Oncology. J Clin Oncol 17:2971–2994

    Article  CAS  Google Scholar 

  23. Jordan K, Schmoll HJ, Aapro MS (2007) Comparative activity of antiemetic drugs. Crit Rev Oncol Hematol 61:162–175

    Article  Google Scholar 

Download references

Acknowledgements

The study was supported by grants from Kaohsiung Veterans General Hospital, Taiwan (VGHKS103-086), and Veterans General Hospital—National Sun Yat-Sen University (VGHNSU103-006), Taiwan.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to An-Jen Chiang.

Ethics declarations

Ethical approval for this study was obtained from the KSVGH Institutional Review Board.

Funding

Hui-Chun Hsu received research funding (VGHKS103-086 and VGHNSU103-006) from Department of Nursing, Kaohsiung Veterans General Hospital, Kaohsiung, Taiwan.

Conflict of interest

The authors declare that they have no conflict of interest.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Hsu, HC., Tsai, SY., Wu, SL. et al. Longitudinal perceptions of the side effects of chemotherapy in patients with gynecological cancer. Support Care Cancer 25, 3457–3464 (2017). https://doi.org/10.1007/s00520-017-3768-7

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00520-017-3768-7

Keywords

Navigation